Standard stroke prevention therapies could by effective in the very elderly, a journal review has claimed, but are under-used for this demographic.
Individuals over the age of 80 who are more susceptible to strokes are highlighted by the review as possible beneficiaries from vascular protection interventions which are effective in younger patients, despite therapeutic drugs being more widely used and becoming more effective.
Emerging data shows that using the routine therapies in treatment of the elderly can be effective.
The claim is part of a review published in the November edition of The Lancet Neurology by Dr Nerses Sanossian and Dr Bruce Ovbiagele from the University of Southern California in America.
The authors conclude: “With the rapidly growing population of individuals above 80 years, future stroke trials need to include the very elderly to facilitate ready generalisability of results and to convince sceptical clinicians that all patients with stroke should benefit from prompt evidence-based treatment, regardless of age.”